Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
Anti-Cancer Agents in Medicinal Chemistry
|
September 1, 2012
The role of focal adhesion kinase in lung cancer
Grace K Dy
Mayo Clinic Proceedings
|
June 13, 2002
31-year-old woman with confusion and labile behavior
Grace K Dy, Vege Santhi Swaroop
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2002
Novel targets for lung cancer therapy: part II
Grace K Dy, Alex A Adjei
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2002
Novel targets for lung cancer therapy: part I
Grace K Dy, Alex A Adjei
CA: a Cancer Journal for Clinicians
|
May 30, 2013
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Grace K Dy, Alex A Adjei
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
November 4, 2005
Obstacles and opportunities in the clinical development of targeted therapeutics
Grace K Dy, Alex A Adjei
Clinical Lung Cancer
|
December 5, 2003
The role of farnesyltransferase inhibitors in lung cancer therapy
Grace K Dy, Alex A Adjei
Cancer
|
September 19, 2008
Systemic cancer therapy: evolution over the last 60 years
Grace K Dy, Alex A Adjei
Clinical Lung Cancer
|
June 13, 2006
Angiogenesis inhibitors in lung cancer: a promise fulfilled
Grace K Dy, Alex A Adjei
Proceedings of the American Thoracic Society
|
April 8, 2009
Emerging therapeutic targets in non-small cell lung cancer
Grace K Dy, Alex A Adjei
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
Anti-Cancer Agents in Medicinal Chemistry
|
September 1, 2012
The role of focal adhesion kinase in lung cancer
Grace K Dy
Mayo Clinic Proceedings
|
June 13, 2002
31-year-old woman with confusion and labile behavior
Grace K Dy, Vege Santhi Swaroop
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2002
Novel targets for lung cancer therapy: part II
Grace K Dy, Alex A Adjei
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2002
Novel targets for lung cancer therapy: part I
Grace K Dy, Alex A Adjei
CA: a Cancer Journal for Clinicians
|
May 30, 2013
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Grace K Dy, Alex A Adjei
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
November 4, 2005
Obstacles and opportunities in the clinical development of targeted therapeutics
Grace K Dy, Alex A Adjei
Clinical Lung Cancer
|
December 5, 2003
The role of farnesyltransferase inhibitors in lung cancer therapy
Grace K Dy, Alex A Adjei
Cancer
|
September 19, 2008
Systemic cancer therapy: evolution over the last 60 years
Grace K Dy, Alex A Adjei
Clinical Lung Cancer
|
June 13, 2006
Angiogenesis inhibitors in lung cancer: a promise fulfilled
Grace K Dy, Alex A Adjei
Proceedings of the American Thoracic Society
|
April 8, 2009
Emerging therapeutic targets in non-small cell lung cancer
Grace K Dy, Alex A Adjei
Page
of 13